286 related articles for article (PubMed ID: 38185043)
1. Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles.
Del Rosario Hernández T; Gore SV; Kreiling JA; Creton R
Biomed Pharmacother; 2024 Feb; 171():116096. PubMed ID: 38185043
[TBL] [Abstract][Full Text] [Related]
2. Finding Drug Repurposing Candidates for Neurodegenerative Diseases using Zebrafish Behavioral Profiles.
Hernández TDR; Gore SV; Kreiling JA; Creton R
bioRxiv; 2023 Sep; ():. PubMed ID: 37745452
[TBL] [Abstract][Full Text] [Related]
3. Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles.
Tucker Edmister S; Del Rosario Hernández T; Ibrahim R; Brown CA; Gore SV; Kakodkar R; Kreiling JA; Creton R
Sci Rep; 2022 Apr; 12(1):6120. PubMed ID: 35449173
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish Larvae Position Tracker (Z-LaP Tracker): a high-throughput deep-learning behavioral approach for the identification of calcineurin pathway-modulating drugs using zebrafish larvae.
Gore SV; Kakodkar R; Del Rosario Hernández T; Edmister ST; Creton R
Sci Rep; 2023 Feb; 13(1):3174. PubMed ID: 36823315
[TBL] [Abstract][Full Text] [Related]
5. A zebrafish model for calcineurin-dependent brain function.
Tucker Edmister S; Ibrahim R; Kakodkar R; Kreiling JA; Creton R
Behav Brain Res; 2022 Jan; 416():113544. PubMed ID: 34425181
[TBL] [Abstract][Full Text] [Related]
6. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
7. Modulation of calcineurin signaling during development.
Tucker Edmister S; Creton R
Dev Neurobiol; 2022 Sep; 82(6):505-516. PubMed ID: 35785416
[TBL] [Abstract][Full Text] [Related]
8. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
Cummings JL; Zhong K
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.
Vargas DM; De Bastiani MA; Zimmer ER; Klamt F
Alzheimers Res Ther; 2018 Jun; 10(1):59. PubMed ID: 29935546
[TBL] [Abstract][Full Text] [Related]
10. Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer's disease.
Neha ; Parvez S
Ageing Res Rev; 2023 Mar; 85():101815. PubMed ID: 36529440
[TBL] [Abstract][Full Text] [Related]
11. Drug repositioning in Alzheimer's disease.
Corbett A; Williams G; Ballard C
Front Biosci (Schol Ed); 2015 Jun; 7(1):184-8. PubMed ID: 25961694
[TBL] [Abstract][Full Text] [Related]
12. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
Lanza V; Milardi D; Di Natale G; Pappalardo G
Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
[TBL] [Abstract][Full Text] [Related]
14. Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
Norins LC
J Alzheimers Dis; 2021; 81(3):921-932. PubMed ID: 33843684
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing for Alzheimer's disease:
Kumar N; Gahlawat A; Kumar RN; Singh YP; Modi G; Garg P
J Biomol Struct Dyn; 2022 Apr; 40(7):2878-2892. PubMed ID: 33170091
[TBL] [Abstract][Full Text] [Related]
16. Medical genetics-based drug repurposing for Alzheimer's disease.
Zhang XZ; Quan Y; Tang GY
Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
[TBL] [Abstract][Full Text] [Related]
17. Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease.
Kim TW
Neurotherapeutics; 2015 Jan; 12(1):132-42. PubMed ID: 25549849
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer's Disease.
Padhi D; Govindaraju T
J Med Chem; 2022 May; 65(10):7088-7105. PubMed ID: 35559617
[TBL] [Abstract][Full Text] [Related]
19. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
[TBL] [Abstract][Full Text] [Related]
20. Repurposing of phyto-ligand molecules from the honey bee products for Alzheimer's disease as novel inhibitors of BACE-1: small molecule bioinformatics strategies as amyloid-based therapy.
Nisa N; Rasmita B; Arati C; Uditraj C; Siddhartha R; Dinata R; Bhanushree B; Bidanchi RM; Manikandan B; Laskar SA; Abinash G; Pori B; Roy VK; Gurusubramanian G
Environ Sci Pollut Res Int; 2023 Apr; 30(17):51143-51169. PubMed ID: 36808033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
